Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Boehringer Ingelheim Pharmaceuticals, Inc.

NDC labeler code: 0597

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

53Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
October 7, 2025NDA218764 Nerandomilast
JASCAYD
Boehringer Ingelheim
August 8, 2025NDA219042 Zongertinib
HERNEXEOS
Boehringer Ingelheim
September 1, 2022BLA761244 Spesolimab
SPEVIGO
Boehringer Ingelheim Pharmaceuticals Inc
June 21, 2021NDA214358 Dabigatran etexilate
PRADAXA
Boehringer Ingelheim
January 27, 2020NDA212614 Empagliflozin, linagliptin, metformin hydrochloride
TRIJARDY XR
Boehringer Ingelheim
December 9, 2016NDA208658 Empagliflozin and metformin hydrochloride
SYNJARDY XR
Boehringer Ingelheim
May 27, 2016NDA208026 Linagliptin and metformin hydrochloride
JENTADUETO XR
Boehringer Ingelheim
October 16, 2015BLA761025 Idarucizumab
PRAXBIND
Boehringer Ingelheim
September 15, 2015NDA207070 Tiotropium
SPIRIVA RESPIMAT
Boehringer Ingelheim
August 26, 2015NDA206111 Empagliflozin and metformin hydrochloride
SYNJARDY
Boehringer Ingelheim
May 21, 2015NDA206756 Tiotropium bromide and olodaterol
STIOLTO RESPIMAT
Boehringer Ingelheim
January 30, 2015NDA206073 Empagliflozin and linagliptin
GLYXAMBI
Boehringer Ingelheim
October 15, 2014NDA205832 Nintedanib
OFEV
Boehringer Ingelheim
September 24, 2014NDA021936 Tiotropium
SPIRIVA RESPIMAT
Boehringer Ingelheim
August 1, 2014NDA204629 Empagliflozin
JARDIANCE
Boehringer Ingelheim
July 31, 2014NDA203108 Olodaterol respimat inhalation spray
STRIVERDI RESPIMAT
Boehringer Ingelheim
July 12, 2013NDA201292 Afatinib
GILOTRIF
Boehringer Ingelheim
January 30, 2012NDA201281 Linagliptin and metformin hydrochloride
JENTADUETO
Boehringer Ingelheim
October 7, 2011NDA021747 Ipratropium bromide and albuterol sulfate
COMBIVENT RESPIMAT
Boehringer Ingelheim
May 2, 2011NDA201280 Linagliptin
TRADJENTA
Boehringer Ingelheim
October 19, 2010NDA022512 Dabigatran etexilate
PRADAXA
Boehringer Ingelheim
November 17, 2004NDA021527 Ipratropium bromide
ATROVENT HFA
Boehringer Ingelheim
January 30, 2004NDA021395 Tiotropium
SPIRIVA
Boehringer Ingelheim
November 17, 2000NDA021162 Telmisartan and hydrochlorothiazide
MICARDIS HCT
Boehringer Ingelheim

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2023

  1. March 9, 2023 · Class II · Terminated · D-0468-2023 · Empagliflozin

    Labeling: Label Mix-up

    JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA an

2022

  1. January 26, 2022 · Class II · Terminated · D-0197-2024 · Tiotropium

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each card contains 10 capsules, Rx only, For oral inhalation only, Distributed by: Boehringer Ingelheim Pharmaceutic

  2. January 26, 2022 · Class II · Terminated · D-0185-2024 · Empagliflozin

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37

2021

  1. March 15, 2021 · Class II · Terminated · D-0458-2021 · Empagliflozin and metformin hydrochloride

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Synjardy XR (empagliflozin and metformin hydrochloride extended-release) Tablets 25 mg/1000 mg 30 tablets Rx only NDC 0597-0295-88 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA

  2. March 15, 2021 · Class II · Terminated · D-0455-2021 · Empagliflozin and linagliptin

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA

  3. March 15, 2021 · Class II · Terminated · D-0456-2021 · Empagliflozin and metformin hydrochloride

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0168-69 Distributed by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA

  4. March 15, 2021 · Class II · Terminated · D-0453-2021 · Tiotropium

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per capsule Rx only NDC 0597-0075-41 Manufactured by: Boehringer Ingelheim (BI) Pharma GmbH & Co. KG Ingelheim, Ge

  5. March 15, 2021 · Class II · Terminated · D-0459-2021 · Empagliflozin and metformin hydrochloride

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Synjardy XR (empagliflozin and metformin) hydrochloride extended-release) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0300-45 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA

  6. March 15, 2021 · Class II · Terminated · D-0457-2021 · Linagliptin and metformin hydrochloride

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets 5 mg/1000 mg 30 tablets Rx only NDC 0597-0275-33 Dist. by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA

2018

  1. September 4, 2018 · Class II · Terminated · D-1217-2018 · Empagliflozin and metformin hydrochloride

    Cross Contamination With Other Products:

    Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI

Show the 4 older recalls

2017

  1. December 14, 2017 · Class II · Terminated · D-0242-2018 · Tiotropium

    Failed Stability Specifications

    SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, C

2015

  1. July 24, 2015 · Class II · Terminated · D-1279-2015 · Ipratropium bromide and albuterol sulfate

    Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.

    COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses per inhaler, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefie

2014

  1. March 27, 2014 · Class III · Terminated · D-1230-2014 · Tiotropium

    Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.

    Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler Only, 18 mcg (as tiotropium) per capsule, Rx Only, a) NDC 0597-0075-75, 5 Spiriva capsules per blister c

2013

  1. August 30, 2013 · Class III · Terminated · D-1057-2013 · Tiotropium

    Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler

    SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules 18 mcg per dose, Rx only, a) 10 count blister (NDC 0597-0075-27), b) 30 count blister (NDC 0597-0075-41), c) 90 count blister (NDC 0597-0075-47), d) 5 co

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →